Published in Elife on January 11, 2016
Cullin3-KLHL25 ubiquitin ligase targets ACLY for degradation to inhibit lipid synthesis and tumor progression. Genes Dev (2016) 0.75
Glutamine Metabolism in Cancer: Understanding the Heterogeneity. Trends Cancer (2017) 0.75
Role of the Transforming Growth Factor-β in regulating hepatocellular carcinoma oxidative metabolism. Sci Rep (2017) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell (1992) 28.36
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology (2007) 26.78
Blinded by the Light: The Growing Complexity of p53. Cell (2009) 17.75
Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci U S A (2007) 15.88
Regulation of cancer cell metabolism. Nat Rev Cancer (2011) 15.44
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature (2009) 13.28
GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol (2005) 10.44
Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell (2012) 9.88
The guanine nucleotide-binding switch in three dimensions. Science (2001) 9.34
Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol (2008) 8.99
Cell migration: Rho GTPases lead the way. Dev Biol (2004) 8.20
Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell (2010) 5.02
Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci U S A (2010) 4.99
Rac1 and Cdc42 capture microtubules through IQGAP1 and CLIP-170. Cell (2002) 4.68
Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc Natl Acad Sci U S A (2010) 4.18
Hepatocellular carcinoma--cause, treatment and metastasis. World J Gastroenterol (2001) 3.95
Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Invest (2013) 3.46
Tools of the trade: use of dominant-inhibitory mutants of Ras-family GTPases. Nat Cell Biol (1999) 3.18
Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World J Gastroenterol (2007) 3.14
Regulation of small GTPases by GEFs, GAPs, and GDIs. Physiol Rev (2013) 3.07
Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat Neurosci (2010) 2.90
ARF6-GTP recruits Nm23-H1 to facilitate dynamin-mediated endocytosis during adherens junctions disassembly. Nat Cell Biol (2002) 2.63
p53 and its mutants in tumor cell migration and invasion. J Cell Biol (2011) 2.49
Crystal structure of Rac1 in complex with the guanine nucleotide exchange region of Tiam1. Nature (2000) 2.37
Metabolic regulation by p53 family members. Cell Metab (2013) 2.00
The mechanism of PAK activation. Autophosphorylation events in both regulatory and kinase domains control activity. J Biol Chem (2001) 1.96
SUMOylation of the GTPase Rac1 is required for optimal cell migration. Nat Cell Biol (2010) 1.95
Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis. J Clin Invest (2015) 1.67
Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism. Proc Natl Acad Sci U S A (2012) 1.54
Tumour-associated mutant p53 drives the Warburg effect. Nat Commun (2013) 1.52
The C-terminal domain of Rac1 contains two motifs that control targeting and signaling specificity. J Biol Chem (2003) 1.45
An improved method for the synthesis of cellulose membrane-bound peptides with free C termini is useful for PDZ domain binding studies. Chem Biol (2004) 1.31
Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion. Oncogene (2004) 1.29
RAC1: an emerging therapeutic option for targeting cancer angiogenesis and metastasis. Mol Cancer Ther (2013) 1.21
Spliced MDM2 isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesis. Nat Commun (2013) 1.19
LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway. Oncotarget (2014) 1.08
Recognition and activation of Rho GTPases by Vav1 and Vav2 guanine nucleotide exchange factors. Biochemistry (2005) 1.08
E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis. Cell Death Differ (2014) 1.07
The C-terminus of human glutaminase L mediates association with PDZ domain-containing proteins. FEBS Lett (2001) 1.06
Outcome and survival analysis of pulmonary metastasectomy for hepatocellular carcinoma. Eur J Cardiothorac Surg (2011) 0.96
Rac1 targeting suppresses p53 deficiency-mediated lymphomagenesis. Blood (2010) 0.92
Rac1 is essential for basement membrane-dependent epiblast survival. Mol Cell Biol (2010) 0.92
Dynamic recruitment of the curvature-sensitive protein ArhGAP44 to nanoscale membrane deformations limits exploratory filopodia initiation in neurons. Elife (2014) 0.92
Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma. Oncotarget (2014) 0.91
Pontin, a new mutant p53-binding protein, promotes gain-of-function of mutant p53. Cell Death Differ (2015) 0.88
BAG2 promotes tumorigenesis through enhancing mutant p53 protein levels and function. Elife (2015) 0.84